Sophiris Bio is a biotech company that develops a treatment for the symptoms of benign prostatic hyperplasia. Their product includes topsalysin for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia and for the treatment of low- to intermediate-risk prostate cancer.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Sophiris Bio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sophiris Bio Inc market cap is $0.00.
What is the 52-week high for Sophiris Bio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sophiris Bio Inc 52 week high is $0.0342 as of September 17, 2025.
What is the 52-week low for Sophiris Bio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sophiris Bio Inc 52 week low is $0.00 as of September 17, 2025.
What was Sophiris Bio Inc stock price yesterday?
Sophiris Bio Inc stock price yesterday was $0.0001.
What is the 50-day moving average of Sophiris Bio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Sophiris Bio Inc 50-day moving average is $0.0001.